General Updates

Date: 15.07.2026 BSE Limited National Stock Exchange of India Limited Dept. of Corporate Services, Dept. of Corporate Compliances, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1 Block-G, Dalal Street, Bandra Kurla Complex, Mumbai- 400 001 Bandra (E) Mumbai- 400 051 BSE Scrip Code - 541304 NSE Symbol: INDOUS Dear Sir/Madam, Subject: Revised Outcome of the Board Meeting held on 10 July 2026. Reconstitution of Committees. With reference to the Outcome of the Board Meeting dated 10 July 2026 submitted by the Company under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that, pursuant to the appointment and resignation of Directors approved by the Board at its meeting held on 21 April 2026, the composition of the Committees of the Board stood reconstituted with effect from 21 April 2026. Accordingly, the Committee composition approved/reported in the Outcome of the Board Meeting dated 10 July 2026 shall be read as effective from 21 April 2026, being the effective date of the appointment and resignation of the concerned Directors. The revised Committee composition is as under: AUDIT COMMITTEE SR. NO. NAME DESIGNATION 1. Ritaben Nileshbhai Kikani Chairperson 2. Shilpa Chetanbhai Thumar Member 3. Jagdishkumar Devjibhai Ajudiya Member 4. Hemanshi Darsh Soni Member NOMINATION AND REMUNERATION COMMITTEE SR. NO. NAME DESIGNATION 1. Shilpa Chetanbhai Thumar Chairperson 2. Ritaben Nileshbhai Kikani Member 3. Hemanshi Darsh Soni Member STAKEHOLDERS RELATIONSHIP COMMITTEE SR. NO. NAME DESIGNATION 1. Ritaben Nileshbhai Kikani Chairperson 2. Jagdishkumar Devjibhai Ajudiya Member 3. Hemanshi Darsh Soni Member 4. Shilpa Chetanbhai Thumar Member Except for the above clarification regarding the effective date of the reconstitution of the Committees, all other disclosures and contents of the Outcome of the Board Meeting dated 10 July 2026 shall remain unchanged. Kindly take the above information on record. Thanking you, Yours faithfully, For, Indo Us Bio-Tech Ltd. Ms. Dimpy Joshi Company Secretary & Compliance officer